Shares Magazine
10.50p-0.30 (-2.86%)07 Nov 2025, 15:22
Jump to:
Immupharma PLC Fundamentals
| Company Name | Immupharma PLC | Last Updated | 2025-11-07 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 502.724 m | Market Cap | £51.28 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.01 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 4.6949 | Cash Equity Ratio | 1.1780 |
| Quick Ratio | 0.4437 | Current Ratio | 1.21 |
| Price To Book Value | 156.2500 | ROCE | 0 |
Immupharma PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Immupharma PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | £82,321.00 | £102,075.00 | £389,718.00 |
| Intangible Assets | £9,822.00 | £447,571.00 | £473,892.00 |
| Investments | 0 | £643,781.00 | £688,350.00 |
| Total Fixed Assets | £92,143.00 | £1.38 m | £1.64 m |
| Stocks | 0 | 0 | 0 |
| Debtors | £189,665.00 | £451,546.00 | £649,401.00 |
| Cash & Equivalents | £236,902.00 | £208,481.00 | £667,813.00 |
| Other Assets | 0 | £184,785.00 | £83,790.00 |
| Total Assets | £977,011.00 | £2.72 m | £3.97 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | £1.52 m | £1.67 m | £1.45 m |
| Creditors after 1 year | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £1.52 m | £1.67 m | £1.45 m |
| Net assets | -£542,859.00 | £1.06 m | £2.52 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | £29.81 m | £29.81 m | £28.98 m |
| Share Premium | £29.32 m | £29.32 m | £28.79 m |
| Profit / Loss | -£2.78 m | -£3.42 m | -£4.46 m |
| Other Equity | -£542,859.00 | £1.06 m | £2.52 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | -£542,859.00 | £1.06 m | £2.52 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | 4.6949 | 4.6949 | 4.6949 |
| Cash / Equity | 1.1780 | 1.1780 | 1.1780 |
| EPS | -£0.01 | -£0.01 | -£0.01 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | -£1.77 m | -£1.36 m | -£2.35 m |
| Cashflow before financing | -£1.27 m | -£642,311.00 | -£799,335.00 |
| Increase in Cash | £24,547.00 | -£453,549.00 | -£876,759.00 |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | 0 | 0 | 0 |
| Cost of sales | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Profit | -£2.68 m | -£3.06 m | -£3.03 m |
| Pre-Tax profit | -£2.78 m | -£3.42 m | -£4.46 m |
Immupharma PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections. |
| Latest Interim Date | 6 Aug 2025 |
| Latest Fiscal Year End Date | 19 May 2025 |
Immupharma PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2021-07-30 | Dr. Franco Di Muzio | Non-Executive Director |
| 2006-03-31 | Mr. Douglas Gordon James Paterson | Non-Executive Director |
| 2025-05-19 | Mr. Timothy Paul McCarthy | Executive Director,Chairman and Chief Executive Officer |
| 2021-07-30 | Mr. Dimitri Dimitriou | Executive Director,Chief Executive Officer |
| 2021-05-24 | Dr. Robert Henri Zimmer | Executive Director,President and Chief Scientific Officer |
| 2016-05-05 | Mr. Richard Leonard Warr | Executive Director,Chairman |
| 2016-05-05 | Dr. Ajay Agrawal | Non-Executive Director |
| 2011-08-09 | Mr. Paddy Hugh Walker-Taylor FCA,MCT | Executive Director,Chief Financial Officer |
| 2006-03-31 | Mr. Anthony Johnson B.Pharm,MSc | Non-Executive Director |
| 2023-08-11 | Dr. Sanjeev Pandya | Non-Executive Director,Senior Independent Director |
| 2021-07-30 | Dr. Stephane Robert George Mery | Non-Executive Director |
| 2025-05-19 | Dr. Timothy Gary Franklin | Executive Director,Chief Operating Officer |
| 2025-05-19 | Ms. Lisa Baderoon | Non-Executive Director,Head of Investor Relations |
| 2025-05-19 | Dr. Robert Reilly Laurence | Non-Executive Director,Senior Independent |
| 2025-05-19 | Dr. Sebastien R. Goudreau | Non-Executive Director |
Immupharma PLC Contact Details
| Company Name | ImmuPharma PLC |
|---|---|
| Address | One Bartholomew Close, London, EC1A 7BL |
| Telephone | +44 2071524080 |
| Website | https://www.immupharma.co.uk |
Immupharma PLC Advisors
| Stockbroker | Bryan, Garnier & Co Limited |
|---|---|
| Phone | +44 2073322500 |
| Nominated Adviser | Northland Capital Partners |
|---|---|
| Phone | +44 2038616625 |
| Fax | +44 2076005975 |
| Stockbroker | Northland Capital Partners |
|---|---|
| Phone | +44 2038616625 |
| Fax | +44 2076005975 |
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
| Auditor | Nexia Smith & Williamson |
|---|---|
| Phone | +44 2071314000 |
| Fax | +44 2071314001 |
| Solicitor | Bircham Dyson Bell |
|---|---|
| Phone | +44 2072277000 |
| Fax | +44 2072223480 |
| Bank | Royal Bank of Scotland PLC |
|---|
| Auditor | Nexia Smith & Williamson Audit Limited |
|---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Itv PLC | 78.65 | 16.17 |
| Oxford Nanopore Technologies PLC | 142.00 | 6.21 |
| Jtc PLC | 1,354.00 | 4.80 |
| Hikma Pharmaceuticals PLC | 1,592.00 | 4.60 |
| Coca-Cola Europacific Partners PLC | 6,940.00 | 3.43 |
| Wpp PLC | 277.70 | 2.74 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Rightmove PLC | 576.60 | -12.02 |
| International Consolidated Airlines Group S.A. | 371.11 | -10.38 |
| Me Group International PLC | 173.60 | -8.44 |
| Baltic Classifieds Group PLC | 265.00 | -7.83 |
| Ceres Power Holdings PLC | 351.71 | -6.71 |
| Auto Trader Group PLC | 756.00 | -5.33 |